D
Diva R. Salomao
Researcher at Mayo Clinic
Publications - 142
Citations - 9040
Diva R. Salomao is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Biopsy & Fine-needle aspiration. The author has an hindex of 35, co-authored 133 publications receiving 8131 citations. Previous affiliations of Diva R. Salomao include Memorial Sloan Kettering Cancer Center.
Papers
More filters
Journal ArticleDOI
Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion
Haidong Dong,Scott E. Strome,Diva R. Salomao,Hideto Tamura,Fumiya Hirano,Dallas B. Flies,Patrick C. Roche,Jun Lu,Gefeng Zhu,Koji Tamada,Vanda A. Lennon,Esteban Celis,Lieping Chen +12 more
TL;DR: It is reported here that, except for cells of the macrophage lineage, normal human tissues do not express B7-H1 and the findings have implications for the design of T cell–based cancer immunotherapy.
Journal Article
B7-H1 Blockade Augments Adoptive T-Cell Immunotherapy for Squamous Cell Carcinoma
Scott E. Strome,Haidong Dong,Hideto Tamura,Stephen G. Voss,Dallas B. Flies,Koji Tamada,Diva R. Salomao,John C. Cheville,Fumiya Hirano,Wei Lin,Jan L. Kasperbauer,Karla V. Ballman,Lieping Chen +12 more
TL;DR: Data support B7-H1 blockade as a new approach to enhance the efficacy of T-cell immunotherapy.
Journal ArticleDOI
Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy.
van Heerden Ja,Ian D. Hay,Goellner,Diva R. Salomao,Ebersold,Erik J. Bergstralh,Clive S. Grant +6 more
TL;DR: FTC, diagnosed on the basis of CI alone, did not result in either distant metastases or cancer-related death, and the dominant determinant of cause-specific mortality was the presence of distant metastase at diagnosis.
Journal ArticleDOI
Small, nonfunctioning, asymptomatic pancreatic neuroendocrine tumors (PNETs): Role for nonoperative management
Louis C. Lee,Clive S. Grant,Diva R. Salomao,Joel G. Fletcher,Naoki Takahashi,Jeff L. Fidler,Michael J. Levy,Marianne Huebner +7 more
TL;DR: Small nonfunctioning PNETs usually exhibit minimal or no growth over many years, and nonoperative management may be advocated when serial imaging demonstrates minimal orNo growth without suspicious features.
Journal ArticleDOI
Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP‐5‐IgG
Shelley A. Cross,Diva R. Salomao,Joseph E. Parisi,Thomas J. Kryzer,Elizabeth A. Bradley,Jonathan A. Mines,Byron L. Lam,Vanda A. Lennon +7 more
TL;DR: Positive serology obviates the need for vitreous biopsy and expedites the search for cancer, as CRMP‐5‐IgG defines a paraneoplastic ophthalmological entity of combined optic neuritis and retinitis with Vitreous inflammatory cells.